Association for Molecular Pathology


October 2010, Volume 16, Number 3


AMP Test Directory

Alexis B. Carter MD

By Alexis B. Carter MD
Editor, AMP Test Directory


The advent of the National Institutes of Health Genetic Test Registry (GTR) initiative has opened up some unique and beneficial opportunities for the AMP Test Directory. AMP leadership has given the proverbial green light for collaborative development of the AMP Test Directory with the GTR. The details are still to be worked out, but I will be visiting Dr. Jim Ostell with the NIH in the next few months in order to further discuss this project. I think it is safe to say that both sides anticipate mutually beneficial outcomes. Details will follow. I welcome any input or wish list items that you may have for the directory.

Many thanks to those of you who took the time to update your directories during the month of July. We have a number of laboratories in the directory that have not been updated in well over a year. We will start the process of communicating with those laboratories shortly to determine if those laboratory listings should be inactivated.

As always, the mission of the AMP Test Directory is to provide a resource to medical personnel of available molecular testing in the United States. As the Test Directory Editor, my responsibilities include reviewing all updates to the Test Directory, regular communication with the Test Directory Programmer and participation in the AMP Publications Committee and now the soon to be operational AMP Web Editorial Board. If you have any questions, ideas or concerns regarding the Test Directory, please do not hesitate to contact me or Mary Williams, MT (ASCP) (